Information Technology [ 10/12 ] | IT Services [ 48/72 ]
NASDAQ | Common Stock
FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business.
Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases.
The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders.
FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 13, 24 | -0.05 Increased by +68.75% | -0.05 |
| Mar 27, 24 | -0.15 Decreased by N/A% | -0.14 Decreased by -7.14% |
| Nov 14, 23 | -0.03 Increased by +83.92% | -0.14 Increased by +78.57% |
| Jul 20, 23 | -0.14 Decreased by -21.65% | - |
| May 12, 23 | -0.16 Increased by 0.00% | - |
| Mar 31, 23 | 0.00 Increased by +100.00% | - |
| Nov 11, 22 | -0.19 Increased by +46.69% | - |
| Aug 12, 22 | -0.12 Increased by +68.88% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 0.00 Decreased by N/A% | -1.13 M Increased by +84.05% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -8.42 M Decreased by -86.65% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -10.89 M Decreased by -88.28% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -5.94 M Increased by +6.42% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -7.09 M Decreased by -22.44% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -4.51 M Increased by +65.86% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -5.78 M Increased by +41.82% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by N/A% | -6.35 M Decreased by -38.93% | Decreased by N/A% Decreased by N/A% |